Identifying immune infiltration pattern of PD-L1 positive and negative lung adenocarcinoma

被引：0
|
作者：
Heidel, C. [1 ,2 ]
Jokic, M. [1 ,2 ]
Faehnrich, A. [3 ]
Kuempers, C. [1 ,2 ]
Vogel, W. [1 ,2 ]
Vlasic, I. [1 ,2 ]
Kirfel, J. [1 ,2 ]
Busch, H. [3 ]
Perner, S. [1 ,2 ]
机构：
[1] Univ Hosp Schleswig Holstein, Inst Pathol, Campus Luebeck, Lubeck, Germany
[2] Leibniz Lung Ctr, Res Ctr Borstel, Pathol, Borstel, Germany
[3] Univ Lubeck, Inst Expt Dermatol, Lubeck, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P407
引用
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [31] Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
    Alexander B. Zaslavsky
    M. P. Adams
    X. Cao
    T. Maj
    J. E. Choi
    J. Stangl-Kremser
    S. Patel
    A. Putelo
    S. K. Lee
    S. Nallandhighal
    A. Kasputis
    A. Alva
    M. Lew
    A. Qin
    R. Mehra
    T. M. Morgan
    S. S. Salami
    Z. Reichert
    A. Udager
    W. Zou
    Ganesh S. Palapattu
    Scientific Reports, 10
  • [32] Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
    Zaslavsky, Alexander B.
    Adams, M. P.
    Cao, X.
    Maj, T.
    Choi, J. E.
    Stangl-Kremser, J.
    Patel, S.
    Putelo, A.
    Lee, S. K.
    Nallandhighal, S.
    Kasputis, A.
    Alva, A.
    Lew, M.
    Qin, A.
    Mehra, R.
    Morgan, T. M.
    Salami, S. S.
    Reichert, Z.
    Udager, A.
    Zou, W.
    Palapattu, Ganesh S.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [33] Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma
    Koh, Young Wha
    Park, Bumhee
    Jung, Se Hee
    Han, Jae-Ho
    Haam, Seokjin
    Lee, Hyun Woo
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [34] Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma
    Zhang, Yan
    Du, Weiwei
    Chen, Zhaoliang
    Xiang, Cheng
    EXPERIMENTAL CELL RESEARCH, 2017, 359 (02) : 449 - 457
  • [35] A positive correlation between the EZH2 and PD-L1 expression in patients with resected lung adenocarcinoma
    Toyokawa, G.
    Takada, K.
    Hamamoto, R.
    Yamada, Y.
    Tagawa, T.
    Shoji, F.
    Yamazaki, K.
    Oda, Y.
    Takeo, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [36] KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
    Nan Chen
    Wenfeng Fang
    Zhong Lin
    Peijian Peng
    Juan Wang
    Jianhua Zhan
    Shaodong Hong
    Jiaxing Huang
    Lin Liu
    Jin Sheng
    Ting Zhou
    Ying Chen
    Hongyu Zhang
    Li Zhang
    Cancer Immunology, Immunotherapy, 2017, 66 : 1175 - 1187
  • [37] Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma
    Yeo, Min-Kyung
    Choi, Song-Yi
    Seong, In-Ock
    Suh, Kwang-Sun
    Kim, Jin Man
    Kim, Kyung-Hee
    HUMAN PATHOLOGY, 2017, 68 : 103 - 111
  • [38] KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
    Chen, Nan
    Fang, Wenfeng
    Lin, Zhong
    Peng, Peijian
    Wang, Juan
    Zhan, Jianhua
    Hong, Shaodong
    Huang, Jiaxing
    Liu, Lin
    Sheng, Jin
    Zhou, Ting
    Chen, Ying
    Zhang, Hongyu
    Zhang, Li
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (09) : 1175 - 1187
  • [39] Emergence of lung cancer with a low PD-L1 expression level after the administration of immune check point inhibitor for lung adenocarcinoma with a high PD-L1 expression level: A case report
    Iwai, Shun
    Funasaki, Aika
    Sekimura, Atsushi
    Motono, Nozomu
    Usuda, Katsuo
    Yamada, Sohsuke
    Ueda, Yoshimichi
    Akasaki, Kyouta
    Tanimura, Kouta
    Kase, Kazumasa
    Uramoto, Hidetaka
    ANNALS OF MEDICINE AND SURGERY, 2020, 56 : 82 - 85
  • [40] The Correlation Among PD-L1 Expression, TMB and Lung Immune Prognostic Index in Chinese Patients with Advanced Lung Adenocarcinoma
    Yuan, P.
    Li, Y.
    Jiang, L.
    Liu, Y.
    Liu, W.
    Ying, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S708 - S709
12345